On the Motion S.Amdt. 1709: Motion To Waive CBA; In the nature of a substitute, the Economic Recovery Act of 1992.Result: Rejected (37-60, 3 members not voting, 3/5 threshold)Details: [click here]
-
This Month
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||
On the Motion S.Amdt. 1709: Motion To Waive CBA; In the nature of a substitute, the Economic Recovery Act of 1992.Result: Rejected (37-60, 3 members not voting, 3/5 threshold)Details: [click here]
On the Motion S.Amdt. 1709: Motion To Waive CBA; In the nature of a substitute, the Economic Recovery Act of 1992.Result: Rejected (37-60, 3 members not voting, 3/5 threshold)Details: [click here]
On the Motion to Table S.Amdt. 1708: Motion To Table S.Amdt.1708; To provide for the containment of prescription drug prices by reducing certain non-research related tax credits to pharmaceutical manufacturers, by establishing the Prescription Drug Policy Review Commission, be requiring a study of the feasibility of establishing a pharmaceutical products price review board, and by…
On the Motion to Table S.Amdt. 1708: Motion To Table S.Amdt.1708; To provide for the containment of prescription drug prices by reducing certain non-research related tax credits to pharmaceutical manufacturers, by establishing the Prescription Drug Policy Review Commission, be requiring a study of the feasibility of establishing a pharmaceutical products price review board, and by…